Abstract
Artificial intelligence (AI) is revolutionizing the diagnosis and treatment of many diseases. A prime example is Type 1 diabetes, the most common endocrine-metabolic disease in children, where AI and new technologies are proving essential in improving glycemic control and the quality of life for those affected. This conference will highlight the advances made in the management and prevention of diabetes, from the discovery of insulin to the use of apps, sensors, and insulin pumps, culminating in the development of the artificial pancreas.